Loading...
*  National Multiple Sclerosis Society
"National Multiple Sclerosis Society Reviews". Glassdoor. Retrieved 2017-05-23. "Working at National Multiple Sclerosis Society ... The National Multiple Sclerosis Society The National Multiple Sclerosis Society - MS Connection. ... The National Multiple Sclerosis Society (NMSS) is a non-profit organization based in New York City with chapters located ... "National Multiple Sclerosis Society on the Forbes The 100 Largest U.S. Charities List". Forbes. Retrieved 2017-05-12. "List of ...
*  Oligoclonal band
... s are an important indicator in the diagnosis of multiple sclerosis. Up to 95% of all patients with multiple ... "Antibodies in multiple sclerosis oligoclonal bands target debris". Proceedings of the National Academy of Sciences. 113: ... Virtanen JO, Wohler J, Fenton K, Reich DS, Jacobson S (2014). "Oligoclonal bands in multiple sclerosis reactive against two ... Correale J, de los Milagros M, Molinas B (2002). "Oligoclonal bands and antibody responses in Multiple Sclerosis". Journal of ...
*  Inflammatory demyelinating diseases of the central nervous system
Marburg multiple sclerosis, an aggressive form, also known as malignant, fulminant or acute MS. Tumefactive multiple sclerosis ... "Multiple sclerosis: one disease or many?". In Thompson AB, Siva A, Kesselring J. Frontiers in Multiple Sclerosis (2nd ed.). ... a subgroup of multiple sclerosis patients with spinal cord and cortical demyelination. In MULTIPLE SCLEROSIS JOURNAL (Vol. 19, ... and sometimes known as borderline forms of multiple sclerosis, is a collection of multiple sclerosis variants, sometimes ...
*  Autoimmune optic neuropathy
Unlike typical optic neuritis, there is no association with multiple sclerosis, but the visual prognosis for AON is worse than ... Furthermore, the workup for multiple sclerosis including MRI, will be negative. Thus, it may be necessary to diagnose AON after ...
*  Clinically isolated syndrome
... like multiple sclerosis (MS) or neuromyelitis optica. In order for such a diagnosis, multiple sites in the central nervous ... "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple ... CIS with enough paraclinical evidence can be considered as a clinical stage of multiple sclerosis (MS). It can also be ... Currently it is considered that the best predictor of future development of clinical multiple sclerosis is the number of T2 ...
*  Interferon beta-1a
... used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and ... "Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative ... Avonex and Rebif are under the top 10 best-selling multiple sclerosis drugs of 2013: It is an example of a specialty drug that ... Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS ...
*  CXCL1
An initial study in mice showed evidence that CXCL1 decreased the severity of multiple sclerosis and may offer a neuro- ...
*  Myelinogenesis
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). A symptom of multiple sclerosis is ... One disease that has significance that affects Myelinogenesis is Multiple Sclerosis. ... "Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis". Discover Medicine. 86: 53-63. ...
*  Multiple Sclerosis International Federation
The Multiple Sclerosis International Federation (MSIF) was established in 1967 as an international body linking the activities ... Since May 2009, MSIF has organised a World Multiple Sclerosis Day, which is now supported by MS organisations in at least 47 ... and to speak out globally on behalf of those affected by multiple sclerosis. MSIF works to achieve its goal through the ... work in worldwide partnership with Member Societies and the International Scientific Community to eliminate multiple sclerosis ...
*  Remyelination
Multiple sclerosis, or MS, is the most prominent of the demyelinating diseases, affecting at least 30 in 100000 people ... While remyelination is very efficient in the early stages of multiple sclerosis, it causes remyelination to fail in the more ... Demyelinating diseases, such as Multiple Sclerosis, have been of utmost interest within the last couple of decades. Recent ... While the early stages of multiple sclerosis are less discernible, the chronic stages can greatly reduce an individual's ...
*  Laquinimod
... as a treatment for relapsing-remitting multiple sclerosis (RRMS) under the brand name Nerventra. Management of multiple ... TEVA)'s experimental multiple sclerosis pill failed to reduce relapses more than placebo in a clinical trial, dealing a blow to ... It is being investigated as an oral treatment for multiple sclerosis (MS). Laquinimod is the successor of Active Biotech's ... April 2000). "Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials". Mult ...
*  TSC2
Tuberous Sclerosis Complex 2 (TSC2), also known as Tuberin, is a protein that in humans is encoded by the TSC2 gene. Mutations ... Alternative splicing results in multiple transcript variants encoding different isoforms of the protein. Together with tuberous ... Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D (2003). "Rheb is a direct target of the tuberous sclerosis tumour suppressor ... Gan B, Yoo Y, Guan JL (2006). "Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 ...
*  Lesional demyelinations of the central nervous system
Marburg multiple sclerosis, an aggressive form, also known as malignant, fulminant or acute MS. Tumefactive Multiple sclerosis ... of multiple sclerosis Internal cerebral veins Great cerebral vein Circle of Willis Dawson Fingers in Multiple Sclerosis [4] ... situation described as tumefactive multiple sclerosis. When they appear alone, they are usually named "Solitary sclerosis", ... "The pathology of multiple sclerosis: a paradigm shift". Curr Opin Neurol. 19: 242-247. doi:10.1097/01.wco.0000227032.47458.cb. ...
*  Interferon beta-1b
The assertion that interferon beta in either form can slow the advance of disability in multiple sclerosis is still unproven. ... Kieseier BC (June 2011). "The mechanism of action of interferon-β in relapsing multiple sclerosis". CNS Drugs. 25 (6): 491-502 ... Freedman MS (January 2011). "Long-term follow-up of clinical trials of multiple sclerosis therapies". Neurology. 76 (1 Suppl 1 ... Medications are modestly effective at decreasing the number of attacks in relapsing-remitting multiple sclerosis and in ...
*  Myelin basic protein
Interest in MBP has centered on its role in demyelinating diseases, in particular, multiple sclerosis (MS). Several studies ... hypothesis of multiple sclerosis has been suggested, in which T cells are, in essence, confusing MBP with human herpesvirus-6. ... they found that the levels of these cross-reactive T cells are significantly elevated in multiple sclerosis patients. Myelin ... "Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event". N. Engl. J. ...
*  Multiple sclerosis
List of multiple sclerosis organizations List of people with multiple sclerosis "NINDS Multiple Sclerosis Information Page". ... National Multiple Sclerosis Society. "Changes in multiple sclerosis disease-course (or "type") descriptions" (PDF). Archived ( ... Currently, the United States National Multiple Sclerosis Society and the Multiple Sclerosis International Federation, describes ... and Marburg multiple sclerosis. There is debate on whether they are MS variants or different diseases. Multiple sclerosis ...
*  Multiple Sclerosis Trust
The Multiple Sclerosis Trust (MS Trust) is an independent, national UK charity that was established in 1993. The MS Trust works ... "Bone marrow cell treatment for chronic multiple sclerosis". MS Trust website. Retrieved 29 November 2012. "Pilates based core ... Research currently being funded includes: University of Bristol, Bone marrow cell treatment for chronic multiple sclerosis ... to provide information for anyone affected by multiple sclerosis, education programmes for health professionals, funding for ...
*  Multiple Sclerosis Journal
The Multiple Sclerosis Journal (formerly Multiple Sclerosis) is a monthly peer-reviewed medical journal covering the clinical ... neurology of multiple sclerosis. The editor-in-chief is Alan J. Thompson (University College London). It was established in ...
*  Malignant multiple sclerosis
The term malignant multiple sclerosis is used to describe MS patients who reach significant level of disability in a short ... Lublin FD, Reingold SC (1996). "Defining the clinical course of multiple sclerosis: Results of an international survey". ... Kurtzke JF (1983). "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)". Neurology ... Feinstein, Anthony (2007). The clinical neuropsychiatry of multiple sclerosis (2nd ed.). Cambridge: Cambridge University Press ...
*  Multiple sclerosis research
Serafeim, Katsavos; Anagnostouli Maria (2013). "Biomarkers in Multiple Sclerosis: An Up-to-Date Overview". Multiple Sclerosis ... "A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis". Multiple Sclerosis. 14 (8): 1076-83. doi: ... Extensive research on multiple sclerosis is being done on what parts of the world have higher rates of MS compared to other ... Miller AE (2011). "Multiple sclerosis: where will we be in 2020?". Mt. Sinai J. Med. 78 (2): 268-79. doi:10.1002/msj.20242. ...
*  Multiple Sclerosis Society
... may refer to: The Multiple Sclerosis Society of Great Britain The Multiple Sclerosis Society of ... Canada The National Multiple Sclerosis Society of the United States. Other multiple sclerosis societies. ...
*  Tumefactive multiple sclerosis
... the world suffer from multiple sclerosis Tumefactive multiple sclerosis cases make up 1 to 2 of every 1000 multiple sclerosis ... yielding a diagnosis of Multiple Sclerosis. Hence the name "tumefactive multiple sclerosis". When the demyelinating lesion ... Tumefactive multiple sclerosis is a condition in which the central nervous system of a person has multiple demyelinating ... link) CS1 maint: Multiple names: authors list (link) National Multiple Sclerosis Society. "Epidemiology of MS". Retrieved 2012- ...
*  Multiple Sclerosis Foundation
MS Focus: The Multiple Sclerosis Foundation, also known as the Multiple Sclerosis Foundation or just MS Focus, is a 501(c)(3) ... Multiple Sclerosis News Today. Retrieved 30 March 2017. "Charity Report - Multiple Sclerosis Foundation - give.org". www.give. ... Multiple Sclerosis News Today. Retrieved 30 March 2017. Ferreira, Leonor Mateus (19 June 2014). "Multiple Sclerosis Foundation ... According to the Better Business Bureau, the Multiple Sclerosis Foundation did not disclose accountability information, and ...
*  Management of multiple sclerosis
CS1 maint: Multiple names: authors list (link) "Multiple sclerosis: its effects on you and those you love" (pdf). Multiple ... Multiple sclerosis. Understanding NICE guidance. Information for people with multiple sclerosis, their families and carers, and ... Neild, Chloe (2009). Women's Health and Multiple Sclerosis (PDF). ISBN 0-921323-99-9. Retrieved 2014-10-25. Multiple Sclerosis ... "EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis ...
*  Multiple sclerosis functional composite
"The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trials". Multiple sclerosis ( ... The multiple sclerosis functional composite is a method of measuring the severity of multiple sclerosis primarily used in ... It was developed over two years from 1994 to 1996 by the National Multiple Sclerosis Society. Rudick, RA; Cutter, G; Reingold, ...
*  David Lander
Lander suffers from multiple sclerosis. Officially diagnosed on 15 May 1984 at Cedars-Sinai Medical Center, he went public in ... He has also worked as the Goodwill Ambassador for the National Multiple Sclerosis Society. He is best known for his portrayal ... David Lander on IMDb David Lander at AllMovie Lenny and the Squigtones at allmusic National Multiple Sclerosis Society. ... In 2002, his autobiography was published, Fall Down Laughing: How Squiggy Caught Multiple Sclerosis and Didn't Tell Nobody ( ...
*  Diagnosis of multiple sclerosis
... and Marburg multiple sclerosis. There is debate on whether they are MS variants or different diseases. Multiple sclerosis ... "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple ... Multiple sclerosis is typically diagnosed based on the presenting signs and symptoms, in combination with supporting medical ... On the other hand, the term malignant multiple sclerosis is used to describe people with MS having reached significant level of ...